Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Cash Conversion Ratio

-4.85×

Quarterly · Period ending:

LCTX logo

LCTX Cash Conversion Ratio

Latest reported-4.85×
LCTX Quarterly Cash Conversion Ratio (0.00× → -4.85×)
High-resolution chart · PNG

LCTX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Cash Conversion Ratio — Quarterly
Period endingCash Conversion Ratio
-4.8509×
1.6901×
-5.8625×
0.1218×
0.1823×
1.2039×
2.0504×
1.9443×
0.9073×
0.8898×
1.2796×
0.728×
1.2477×
2.6144×
1.3042×
0.9501×
1.0586×
-3.0842×
0.2076×
0.6284×
1.1552×
5.2507×
-2.7879×
0.6277×
0.6509×
0.5996×
1.2338×
0.4551×
0.3284×
-0.2412×
0.1519×
-0.1284×
1.7649×
0.1784×
0.0844×
-0.5682×
0.801×
-0.1685×
1.8203×
-0.301×
-0.4504×
0.8861×
1.1127×
0.9601×
1.2813×
0.9287×
0.8608×
1.0524×
1.1503×
1.3075×
0.4552×
0.8505×
1.0176×
0.9739×
0.8603×
1.0207×
0.732×
1.173×
0.7043×
1.0268×
0.7101×
1.1614×
1.0259×
0.4326×
0.8144×
1.1252×
-0.614×
0.415×
0.6365×
0.6778×
0.8755×
0.0641×
1.1365×
0.5706×
1.0991×
0.7189×
1.0173×
0.6928×
0.5139×
0.6998×
0.1343×
1.5575×
-0.7122×
1.5921×
1.0011×
0.907×
0.3614×
0.4032×
0.875×
0.4683×
0.7764×
1.4672×
0.212×
0.7468×
0.6604×
0.8031×
0.6208×
0.9418×
0.4566×
1.2245×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.